Jade Biosciences (JBIO) Other Accumulated Expenses (2020 - 2025)

Jade Biosciences (JBIO) has 6 years of Other Accumulated Expenses data on file, last reported at $429000.0 in Q1 2025.

• Quarterly Other Accumulated Expenses fell 36.35% year-over-year to $429000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $429000.0 (down 36.35% YoY) and the FY2024 annual result came in at $319000.0, down 70.73% from the prior year.
• Other Accumulated Expenses improved to $429000.0 in Q1 2025, from $319000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q4 2023 to a low of $120000.0 in Q2 2021.
• A 5-year average of $388500.0 and a median of $305500.0 in 2024 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses jumped 694.44% — and 2024, when it sank 70.73%.
• Tracing JBIO's Other Accumulated Expenses over 5 years: stood at $143000.0 in 2021, then surged by 165.73% to $380000.0 in 2022, then surged by 186.84% to $1.1 million in 2023, then slumped by 70.73% to $319000.0 in 2024, then soared by 34.48% to $429000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $429000.0 (Q1 2025), $319000.0 (Q4 2024), and $292000.0 (Q3 2024), per Business Quant data.